Navigation Links
Khloe Kardashian Receives Body Contouring VelaShape(TM) Treatment Before Photo Shoot
Date:3/19/2009

Body shaping (through circumferential reduction) treatment by Syneron(TM) exposed as celebrity beauty secret

IRVINE, Calif., March 19 /PRNewswire/ -- Khloe Kardashian, celebrity and star of the E! show Keeping up with the Kardashians, receives the VelaShape(TM) (http://velashape.com) treatment for cellulite reduction and body contouring through circumferential reduction during the March 22 episode airing at 10/9c.

In the episode, Khloe prepares her body for an upcoming photo shoot for a charity ad campaign. Khloe visits Dr. Shalini Kapoor-Grover of REVIVE: Beverly Hills Medical Institute and receives VelaShape treatments on her stomach.

VelaShape, clinically proven to take inches off the thighs, is a celebrity beauty secret that has been embraced by not only Khloe but also her sister, Kim Kardashian.

"For women already in great shape, like Khloe Kardashian, VelaShape helps smooth and contour curves," said Dr. Shalini. "My VelaShape patients include men and women looking to not only smooth the top layer of the skin but also to even out stubborn pockets of fat on the thighs, buttocks, stomach, back and arms that are not reduced with diet and exercise alone."

VelaShape, developed by Syneron(TM) Medical Ltd. (Nasdaq: ELOS), tightens and tones flabby skin through heat, vacuum and massage to reduce or shrink the size of the actual fat cells and fat chambers. In four to six treatments, each spaced one week apart, the non-invasive VelaShape dramatically improves the appearance of problem areas including the arms, love handles, buttocks, stomach and thighs.

In a recent poll of 195 VelaShape treatment providers, more than 84 percent reported VelaShape resulted in an average circumferential reduction of one to two inches, 14 percent reported an average of two to four inches and two percent reported an average reduction of five inches or more.

To find a VelaShape treatment provider near you or for more information, please visit http://www.velashape.com. Catch new episodes of Keeping up with the Kardashians Sundays at 10/9c.

About Syneron

Syneron Medical Ltd. (Nasdaq: ELOS) manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented elos(TM) combined-energy technology of bi-polar radio frequency and light. The Company's innovative elos technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, cellulite, circumferential reduction and the treatment of acne, leg veins and laser-assisted lipolysis. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron has offices and distributors throughout the world, including North American headquarters in Irvine, California, and Asia-Pacific headquarters in Hong Kong, which provide sales, service and support. Additional information can be found at http://www.syneron.com.

Syneron, the Syneron logo, VelaShape and elos are trademarks of Syneron Medical Ltd. and may be registered in certain jurisdictions. Elos (Electro-Optical Synergy) is a proprietary technology of Syneron Medical. All other names are the property of their respective owners.

    For more information, please contact:

    Angela Leon, Airfoil PR for Syneron
    248-304-1445
    leon@airfoilpr.com


'/>"/>
SOURCE Syneron Medical Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kim Kardashian and Tia Carrere Celebrate Premiere of Revolutionary CellCeuticals(R) Biomedical Skin Treatments at Social Hollywood with Founders Dr. Garth Fisher and Paul Scott Premo
2. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
3. DaVita Receives Civil Complaint
4. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
5. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
6. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
8. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
9. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
10. Prime Therapeutics Receives TIPPS Certification
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... ... 2017 , ... Ecommerce sales have grown every year since the 1990’s, with ... The consequences of rapid innovation and growth are often neglected in the name of ... business and individual’s job to give something back to the planet that provides the ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article in ... teeth, which reveal a great deal about prehistoric ice-age dental practitioners and their primitive ... been used to remove decayed dental matter, and that teeth were then filled with ...
(Date:4/21/2017)... CITY, Utah (PRWEB) , ... April 21, 2017 ... ... of wilderness therapy treatment for adolescents and young adults, has kicked off its ... 20th-Sunday, April 23rd. This year’s theme is “Attachment Informed Therapy for Mental ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of The Beryl ... 2017 Ruth Ravich Patient Advocacy Award in recognition of her extraordinary contributions ... with the award at The Beryl Institute’s annual Patient Experience Conference on ...
(Date:4/21/2017)... ... April 21, 2017 , ... Alive for Wellness is ... overcome their mental health struggles. The Alive team uses advanced behavioral sciences treatment ... in dealing with a mental health struggle is based on 10 modalities of ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., ... case series to be presented at the 2017 National ... begins today and continues through April 22. Physicians will ... , used to assess risk for acute kidney injury ... heart failure (ADHF). Elevated levels of ...
(Date:4/18/2017)... , April 18, 2017  Socionext Inc. and ... started in 2016, in which Socionext extracts and ... The companies achieved initial results in reading ultrasound ... Artificial Brain SOINN. The results will be introduced ... April 19-21, at booths 4505 & 4507. ...
(Date:4/18/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company founded ... infections, will present preclinical data supporting the use of ... (MDR) Gram-negative infections at the 27th European Congress of ... in Vienna, Austria . ... "Our ongoing preclinical ...
Breaking Medicine Technology: